Sylvie Feldman-Billard

4PUBLICATIONS
0CO-AUTHORS
Major global burdens of diseaseEpidemiological modellingFood properties (incl. characteristics and health benefits)Exercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 20, 2023
Comment on Lundeen et al. Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years. Diabetes Care 2023;46:687-696.

Sylvie Feldman-Billard, Pascale Massin, Catherine Creuzot-Garcher

|Jan 20, 2022
Comment on Lee et al. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study. Diabetes Care 2021;44:2419-2426.

Sylvie Feldman-Billard, Michel Paques

|Feb 28, 2019
Comment on Wang et al. Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults. Diabetes Care 2018;41:1998-2009.

Sylvie Feldman-Billard

|Nov 23, 2017
Comment on Kaul. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821-831.

Sylvie Feldman-Billard

Pageof 1

Frequent Collaborators